Case report: Self-administration of alpha-1 antitrypsin therapy: a report of two cases
Intravenous augmentation therapy with human alpha-1 proteinase inhibitor for the management of respiratory disease is recommended for people with alpha-1 antitrypsin deficiency (AATD) who are nonsmokers or former smokers. Augmentation therapy usually requires weekly administration at the hospital or...
Saved in:
Main Authors: | Ana M. Escribano Dueñas (Author), Mónica Martín García (Author), Begoña Tortajada Goitia (Author), José Javier Arenas Villafranca (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cystic fibrosis and alpha-1 antitrypsin deficiency: case report and review of literature
by: Evi Jaspers, et al.
Published: (2022) -
Alpha-1-Antitrypsin Deficiency in Children: Case Series
by: Svetlana I. Melnik, et al.
Published: (2016) -
Alpha-1 Antitrypsin Deficiency: Home Therapy
by: Anna Annunziata, et al.
Published: (2021) -
Case Report: When cystic fibrosis, elexacaftor/tezacaftor/ivacaftor therapy, and alpha1 antitrypsin deficiency get together
by: Rachel Kinuani, et al.
Published: (2024) -
Cutaneous manifestation of Alpha-1 antitrypsin deficiency: A case of panniculitis
by: Sofia Lopes, et al.
Published: (2018)